<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35265728</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms.</ArticleTitle><Pagination><StartPage>ofac060</StartPage><MedlinePgn>ofac060</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofac060</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofac060</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">We aimed to describe the clinical presentation of individuals presenting with prolonged recovery from coronavirus disease 2019 (COVID-19), known as long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was an analysis within a multicenter, prospective cohort study of individuals with a confirmed diagnosis of COVID-19 and persistent symptoms &gt;4 weeks from onset of acute symptoms. We performed a multiple correspondence analysis (MCA) on the most common self-reported symptoms and hierarchical clustering on the results of the MCA to identify symptom clusters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Two hundred thirty-three individuals were included in the analysis; the median age of the cohort was 43 (interquartile range [IQR], 36-54) years, 74% were women, and 77.3% reported a mild initial illness. MCA and hierarchical clustering revealed 3 clusters. Cluster 1 had predominantly pain symptoms with a higher proportion of joint pain, myalgia, and headache; cluster 2 had a preponderance of cardiovascular symptoms with prominent chest pain, shortness of breath, and palpitations; and cluster 3 had significantly fewer symptoms than the other clusters (2 [IQR, 2-3] symptoms per individual in cluster 3 vs 6 [IQR, 5-7] and 4 [IQR, 3-5] in clusters 1 and 2, respectively; <i>P</i>&#x2005;&lt;&#x2005;.001). Clusters 1 and 2 had greater functional impairment, demonstrated by significantly longer work absence, higher dyspnea scores, and lower scores in SF-36 domains of general health, physical functioning, and role limitation due to physical functioning and social functioning.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Clusters of symptoms are evident in long COVID patients that are associated with functional impairments and may point to distinct underlying pathophysiologic mechanisms of disease.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCann</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Conor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Belfield, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savinelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinago</LastName><ForeName>Willard</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousif</LastName><ForeName>Obada</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Endocrinology Department, Wexford General Hospital, Carricklawn, Wexford, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Belfield, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Broin</LastName><ForeName>Cathal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feeney</LastName><ForeName>Eoin R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Barra</LastName><ForeName>Eoghan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Beaumont Hospital, Beaumont, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doran</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Belfield, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallon</LastName><ForeName>Patrick W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Vincent's University Hospital, Elm Park, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>All-Ireland Infectious Diseases (AIID) Cohort Study Group </CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2</Keyword><Keyword MajorTopicYN="N">2 infection</Keyword><Keyword MajorTopicYN="N">CoV</Keyword><Keyword MajorTopicYN="N">SARS</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post&#x2013;acute sequelae of SARS</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Cotter</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muldoon</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheehan</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGinty</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lambert</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leamy</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kenny</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCann</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCann</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Broin</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waqas</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savinelli</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feeney</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mallon</LastName><ForeName>P W G</ForeName><Initials>PWG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia Leon</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miles</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alalwan</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Negi</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Barra</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McConkey</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurley</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sulaiman</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horgan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadlier</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eustace</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kelly</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bracken</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whelan</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Low</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yousif</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNicholas</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Courtney</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gavin</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35265728</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pii">ofac060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv [Preprint]. Posted online 3 July 2021. doi:10.1101/2021.06.28.21259452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence.
 COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020. https://www.nice.org.uk/guidance/ng188. Accessed 23 August 2021.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention.
Post-COVID conditions: information for healthcare providers. 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Fclinical-care%2Flate-sequelae.html. Accessed 23 August 2021.</Citation></Reference><Reference><Citation>
World Health Organization.
A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. https://apps.who.int/iris/handle/10665/345824. Accessed 1 December 2021.</Citation></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, et al. . Prevalence and predictors of post-acute COVID-19 syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One 2021; 16:e0260568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. . Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci 2021; 46:428&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9:1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky JR, Tao G, Lavery AM, et al. . Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data&#x2014;United States, March 1&#x2013;June 30, 2020. Clin Infect Dis 2021; 73(Suppl 1):S5&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailly S, Destors M, Grillet Y, et al. . Obstructive sleep apnea: a cluster analysis at time of diagnosis. PLoS One 2016; 11:e0157318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4912165</ArticleId><ArticleId IdType="pubmed">27314230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciascia S, Radin M, Cecchi I, et al. . Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Rheumatology 2021; 60:1106&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">31840749</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization.
COVID-19 clinical management living guidance. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2. Accessed 13 February 2022.</Citation></Reference><Reference><Citation>Stenton C. The MRC breathlessness scale. Occup Med 2008; 58:226&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18441368</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake C, Codd MB, O&#x2019;Meara YM.. The Short Form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci 2000; 169:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">11272876</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Franco G. Multiple correspondence analysis: one only or several techniques? Qual Quant 2016; 50:1299&#x2013;315.</Citation></Reference><Reference><Citation>
Husson F, Josse J, Le S, Mazet J.. 
Package &#x2018;FactoMineR.&#x2019;
2020. https://cran.rediris.es/web/packages/FactoMineR/FactoMineR.pdf. Accessed 23 August 2021.</Citation></Reference><Reference><Citation>Wong TL, Weitzer DJ.. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021; 57:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al. . Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 2021; 7:e001735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med 2011; 270:327&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, et al. . Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2021; 6:116&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro-Perez M, Martin-Garcia A, et al. . Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv [Preprint]. Posted online 14 July 2020. doi:10.1101/2020.07.12.20151316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5:1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>
Mayhew M, Kerai G, Ainslie D.. 
Coronavirus and the social impacts of &#x201c;long COVID&#x201d; on people&#x2019;s lives in Great Britain: 7 April to 13 June 2021. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronavirusandthesocialimpactsoflongcovidonpeopleslivesingreatbritain/7aprilto13june2021. Accessed 22 September 2021.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, et al. . Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis 2021; 73:e826&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al. . Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 2021; 18:997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, et al. . Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol 2021; 288:103644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, et al. . Persistent exertional intolerance after COVID-19. Chest 2021; 161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Faini A, et al. . Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol 2021; 130:1470&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM, et al. . Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J 2021; 58:2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. . Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med 2021; 21:e63&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin JM, Quer G, Ramos E, et al. . Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open 2021; 4:e2115959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264646</ArticleId><ArticleId IdType="pubmed">34232306</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Moloney D, Finucane C, et al. . Fatigue following COVID-19 infection is not associated with autonomic dysfunction. PLoS One 2021; 16:e0247280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906457</ArticleId><ArticleId IdType="pubmed">33630906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA.. COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol 2022; 27:100284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D&#x2019;Addio F, et al. . Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 2021; 3:775&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V, Pariante CM.. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf Open Immunol 2021; 2:iqab004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluka KA, Clauw DJ.. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 2016; 338:114&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5083139</ArticleId><ArticleId IdType="pubmed">27291641</ArticleId></ArticleIdList></Reference><Reference><Citation>Light AR, White AT, Hughen RW, Light KC.. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain 2009; 10:1099&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757484</ArticleId><ArticleId IdType="pubmed">19647494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D, et al. . Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey [manuscript published online ahead of print 26 November 2021]. Clin Infect Dis 2021. doi:10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>